-
公开(公告)号：US07540427B2
公开(公告)日：2009-06-02
申请号：US10514495
申请日：2003-05-14
IPC分类号： G06K19/06
CPC分类号： G06K19/0739 , G06K19/07749
摘要： The present invention provides an IC tag which has a structure comprising a first adhesive layer formed on a surface of a substrate sheet, an electronic circuit and an IC chip connecting both ends of the electronic circuit, both formed on the surface of the first adhesive layer, and a second adhesive layer covering the electronic circuit and the IC chip. The IC tag further includes a release agent layer formed at positions corresponding to the both ends of the electronic circuit and located at the interface between the substrate sheet and the first adhesive layer. When the IC tag attached to an article is peeled off, the built-in electronic circuit is surely broken.
摘要翻译： 本发明提供一种IC标签，其具有包括形成在基板的表面上的第一粘合层，连接电子电路的两端的电子电路和IC芯片，二者形成在第一粘合层的表面上 以及覆盖电子电路和IC芯片的第二粘合层。 IC标签还包括形成在对应于电子电路的两端的位置并且位于基板和第一粘合剂层之间的界面处的脱模剂层。 当附着在物品上的IC标签被剥离时，内置的电子电路肯定会损坏。
-
公开(公告)号：US20090011923A1
公开(公告)日：2009-01-08
申请号：US12204006
申请日：2008-09-04
IPC分类号： C04B35/468
CPC分类号： H05K1/162 , C04B35/4682 , C04B35/49 , C04B2235/3203 , C04B2235/3206 , C04B2235/3208 , C04B2235/3213 , C04B2235/3215 , C04B2235/3236 , C04B2235/3251 , C04B2235/3262 , C04B2235/3281 , C04B2235/3282 , C04B2235/3284 , C04B2235/3298 , C04B2235/656 , C04B2235/77 , H01G4/1227 , H01G4/30 , H01L2224/16227 , H01L2224/16235 , H01L2224/16268 , H05K1/0306 , H05K3/4688 , H05K2201/0187
摘要： The present invention provides a dielectric porcelain composition comprising 100 parts by weight of a barium titanate-based dielectric material and 4 to 10 parts by weight in total of Bi2O3 and at least one compound selected from the group of consisting of CuO, ZnO and MgO.
摘要翻译： 本发明提供一种电介质瓷组合物，其包含100重量份的钛酸钡基电介质材料和4至10重量份的Bi 2 O 3和至少一种选自CuO，ZnO和MgO的化合物。
-
公开(公告)号：US08273916B2
公开(公告)日：2012-09-25
申请号：US12872384
申请日：2010-08-31
IPC分类号： C07B57/00
CPC分类号： C07C53/128
摘要： According to the present invention, crystals comprising (2R)-2-propyloctanoic acid and an amine, which can be used as bulk drugs for safely orally administrable solid preparations with keeping the pharmacological effect, are provided. Among these crystals, the crystal with dibenzylamine per se is particularly useful as bulk drug for pharmaceuticals and can be used as an intermediate to produce (2R)-2-propyloctanoic acid having an optical purity of more than 99.5% e.e. which has not been obtained.
摘要翻译： 根据本发明，提供了包含（2R）-2-丙基辛酸和胺的晶体，其可以用作用于安全口服给药的固体制剂的主要药物，并具有药理作用。 在这些晶体中，具有二苄基胺本身的结晶特别可用作药物的大量药物，并且可以用作中间体以产生光学纯度大于99.5％e.e的（2R）-2-丙基辛酸。 尚未获得。
-
24.发明申请公开(公告)号：US20120190427A1
公开(公告)日：2012-07-26
申请号：US13435632
申请日：2012-03-30
IPC分类号： A63F13/00
CPC分类号： G07F17/3267 , G07F17/3202 , G07F17/3211
摘要： A gaming machine of the present invention performs an effect of rotating an image displayed in each display block having a second specific symbol rearranged therein in a direction so as to turn a display screen of a display over to the other side after scroll-displaying a specific character image to the display in a direction from one side of a symbol display region toward the opposite side, and also changing the second specific symbol rearranged in the each display block into a first specific symbol, when the first specific symbol and the second specific symbol have been rearranged in the symbol display region and also when it has been determined to display the specific character image; and offers an award in accordance with the number of first specific symbols arranged in the symbol display region as a result thereof.
摘要翻译： 本发明的游戏机执行旋转显示在具有第二特定符号的每个显示块中的图像的方向，以便在滚动显示特定的图像之后将显示的显示屏幕转到另一侧 字符图像在从符号显示区域的一侧朝向相反侧的方向上显示，并且当第一特定符号和第二特定符号在每个显示块中重新排列为第一特定符号时，将第二特定符号改变为第一特定符号 已被重新排列在符号显示区域中，并且当已经确定显示特定字符图像时; 并作为其结果，根据排列在符号显示区域中的第一特定符号的数量提供奖励。
-
公开(公告)号：US20110314782A1
公开(公告)日：2011-12-29
申请号：US13142225
申请日：2009-10-20
IPC分类号： B01D46/52
CPC分类号： B01D46/523 , B01D2265/04 , B01D2275/20 , B01D2275/50
摘要： The invention provides a filter pack of which the mass is not increased, and moreover, the effective filter medium area is not reduced, and of which the pressure drop is sufficiently low, and the strength is sufficiently high, and an air filter using this.A pleated air filter pack is configured in such a way that dot embossed projections are provided on front and rear surfaces of a filter medium made of a non-woven fabric, the filter medium is folded in zigzag shape along creases of pleats, and the opposing embossed projections are brought into contact with each other when the filter medium is folded, thus maintaining the intervals between the filter media.
摘要翻译： 本发明提供了一种不增加质量的过滤器组件，此外，有效过滤介质面积不降低，其压降足够低，强度足够高，并且使用这种空气过滤器。 打褶的空气过滤器组件以这样的方式构造，即在由无纺织物制成的过滤介质的前表面和后表面上设置点压花突起，过滤介质沿褶皱褶皱折叠成Z字形， 当过滤介质折叠时，压花突起彼此接触，从而保持过滤介质之间的间隔。
-
公开(公告)号：US20100331414A1
公开(公告)日：2010-12-30
申请号：US12872384
申请日：2010-08-31
CPC分类号： C07C53/128
摘要： According to the present invention, crystals comprising (2R)-2-propyloctanoic acid and an amine, which can be used as bulk drugs for safely orally administrable solid preparations with keeping the pharmacological effect, are provided. Among these crystals, the crystal with dibenzylamine per se is particularly useful as bulk drug for pharmaceuticals and can be used as an intermediate to produce (2R)-2-propyloctanoic acid having an optical purity of more than 99.5% e.e. which has not been obtained.
摘要翻译： 根据本发明，提供了包含（2R）-2-丙基辛酸和胺的晶体，其可以用作用于安全口服给药的固体制剂的主要药物，并具有药理作用。 在这些晶体中，具有二苄基胺本身的结晶特别可用作药物的大量药物，并且可以用作中间体以产生光学纯度大于99.5％e.e的（2R）-2-丙基辛酸。 尚未获得。
-
27.发明授权公开(公告)号：US07589221B2
公开(公告)日：2009-09-15
申请号：US10560176
申请日：2004-06-09
IPC分类号： C07B53/00 , C07C231/00 , C07C227/00
CPC分类号： C07C53/128 , C07B2200/07 , C07C231/06 , C07C309/73
摘要： The present invention relates to a process for producing (2R)-2-propyloctanoic acid, which comprises subjecting (2R)-2-hexyloxirane to a two-carbon adding reaction with ring-opening reaction, followed by a protecting reaction of a hydroxyl group to convert it to a compound represented by formula (I): (wherein X represents an optionally protected hydroxyl group) and then subjecting the compound to a one-carbon adding reaction to convert it to (2R)-2-propyloctanamide, followed by recrystallization and hydrolysis. According to the process of the present invention, (2R)-2-propyloctanoic acid can be produced by less steps as compared with the conventional method without a dangerous reaction.
摘要翻译： 本发明涉及（2R）-2-丙基辛酸的制备方法，其包括使（2R）-2-己氧基丙烯在开环反应中进行二碳加成反应，接着进行羟基的保护反应 将其转化为由式（I）表示的化合物：（其中X表示任选保护的羟基），然后使化合物进行一碳加成反应，将其转化为（2R）-2-丙基辛酰胺，然后重结晶 和水解。 根据本发明的方法，与没有危险反应的常规方法相比，可以通过较少的步骤制备（2R）-2-丙氧基辛酸。
-
公开(公告)号：US20070167522A1
公开(公告)日：2007-07-19
申请号：US10564720
申请日：2004-07-14
申请人： Haruo Imawaka , Tomoyuki Hasegawa , Shigeru Sakuyama , Yasufumi Kawanaka , Tsutomu Akiyama , Masamitsu Hoshikawa , Saiko Matsuda
发明人： Haruo Imawaka , Tomoyuki Hasegawa , Shigeru Sakuyama , Yasufumi Kawanaka , Tsutomu Akiyama , Masamitsu Hoshikawa , Saiko Matsuda
IPC分类号： A61K31/20
CPC分类号： C07C59/185 , C07C59/01
摘要： The present invention relates to a compound represented by formula (I) wherein R1 represents optionally protected hydroxy or oxo, indicates α-configuration, β-configuration or a mixture of these in an arbitary proportion, n represents an integer of 1 to 3, and m represents 0 or an integer of 1 to 10; and wherein two or more R1's are not bound to the same carbon atom other than the terminal carbon atom, a salt thereof or a prodrug thereof. The compounds represented by formula (I) have an ability to improve astrocyte function, and they are useful as a preventive and/or therapeutic agent for a brain infarction, neuronal dysfunction by brain infarction, Parkinson's disease, Parkinson's syndrome, amyotrophic lateral sclerosis or Alzheimer's disease.
摘要翻译： 本发明涉及由式（I）表示的化合物，其中R 1表示任选保护的羟基或氧代，
表示alpha配置，beta配置或这些 任意比例，n表示1〜3的整数，m表示0或1〜10的整数， 并且其中两个或更多个R 1不与除了末端碳原子之外的相同碳原子，其盐或其前药结合。 由式（I）表示的化合物具有改善星形胶质细胞功能的能力，并且它们可用作脑梗塞的预防和/或治疗剂，脑梗死的神经元功能障碍，帕金森病，帕金森综合征，肌萎缩性侧索硬化或阿尔茨海默病 疾病。
-
29.发明授权Indole compounds, process for producing the same and drugs containing the same as the active ingredient 失效吲哚化合物，其制备方法和含有与活性成分相同的药物公开(公告)号：US07153852B2
公开(公告)日：2006-12-26
申请号：US10488834
申请日：2002-09-06
IPC分类号： A61K31/538 , A61K31/404 , C07D265/36 , C07D209/08
CPC分类号： C07D405/12 , A61K31/405 , A61K31/538 , C07D209/08 , C07D209/12 , C07D411/12 , C07D413/12
摘要： Indole derivatives represented by formula (I) wherein all symbols represent the same as that in specification), production methods thereof, and DP receptor antagonist comprising them as active ingredients.Since the compounds of formula (I) binds and antagonizes to DP receptor, they are useful for the prevention and/or treatment against allergic diseases, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, cerebrovascular disorder, pleuritis complicated by rheumatoid arthritis, ulcerative colitis.
摘要翻译： 其中所有符号表示与说明书中相同的式（I）表示的吲哚衍生物，其制备方法和包含它们作为活性成分的DP受体拮抗剂。 由于式（I）化合物与DP受体结合并拮抗，它们可用于预防和/或治疗过敏性疾病，伴有瘙痒的疾病，由瘙痒引起的行为，炎症，慢性阻塞性肺病， 缺血再灌注障碍，脑血管障碍，类风湿关节炎并发溃疡性结肠炎的胸膜炎。
-
30.发明申请Indole derivatives, process for producing the same and drugs containing the same as the active ingredient 失效吲哚衍生物，其制备方法和含有与活性成分相同的药物公开(公告)号：US20050004096A1
公开(公告)日：2005-01-06
申请号：US10488834
申请日：2002-09-06
IPC分类号： A61K31/405 , A61K31/538 , A61P1/00 , A61P7/00 , A61P7/02 , A61P9/08 , A61P11/00 , A61P11/02 , A61P11/06 , A61P17/00 , A61P25/20 , A61P27/02 , A61P29/00 , A61P31/00 , A61P37/08 , A61P43/00 , C07D209/08 , C07D209/12 , C07D405/12 , C07D411/12 , C07D413/12 , A61K31/454 , C07
CPC分类号： C07D405/12 , A61K31/405 , A61K31/538 , C07D209/08 , C07D209/12 , C07D411/12 , C07D413/12
摘要： Indole derivatives represented by formula (I) wherein all symbols represent the same as that in specification), production methods thereof, and DP receptor antagonist comprising them as active ingredients. Since the compounds of formula (I) binds and antagonizes to DP receptor, they are useful for the prevention and/or treatment against allergic diseases, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, cerebrovascular disorder, pleuritis complicated by rheumatoid arthritis, ulcerative colitis.
摘要翻译： 其中所有符号表示与说明书中相同的式（I）表示的吲哚衍生物，其制备方法和包含它们作为活性成分的DP受体拮抗剂。 由于式（I）化合物与DP受体结合并拮抗，它们可用于预防和/或治疗过敏性疾病，伴有瘙痒的疾病，由瘙痒引起的行为，炎症，慢性阻塞性肺病， 缺血再灌注障碍，脑血管障碍，类风湿关节炎并发溃疡性结肠炎的胸膜炎。
-
-
-
-
-
-
-
-
-
搜索结果
30 条记录 (耗时 0.039 秒)
